Dr. Kiana Aran, a distinguished alumna of Rutgers University School of Engineering, has made groundbreaking contributions to the field of bioengineering and nanotechnology. Earning her Ph.D. in Biomedical Engineering from Rutgers in 2012, Dr. Aran’s research laid the foundation for her pioneering work in biosensors and bioelectronics, bridging engineering and life sciences to develop innovative healthcare solutions.
During her time at Rutgers, Dr. Aran was actively involved in cutting-edge research initiatives, focusing on developing nanoscale technologies for medical diagnostics. Her work contributed to Rutgers Engineering’s reputation as a leader in biomedical innovation, fostering collaborations between academia and industry to advance personalized medicine and genetic analysis technologies.
Post-Rutgers, Dr. Aran continued her impressive career as the co-founder of CRISPR QC and former Chief Science Officer of Cardea Bio, where she developed the groundbreaking CRISPR-Chip technology—an invention that integrates CRISPR-Cas systems with graphene-based electronics for rapid genetic detection. Her achievements in bioengineering have earned her numerous accolades, including the prestigious 2021 Nature – Estée Lauder Research Award for Inspiring Women in Science.